tiprankstipranks
Trending News
More News >
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market

Recursion Pharmaceuticals (RXRX) Revenue

Compare
4,273 Followers

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had a revenue of 5.17M in the quarter ending Sep 30, 2025, with -72.91%. This bring the company's revenue in the last twelve months to 43.53M, Increased -32.44%. In the fiscal year ending Dec 31, 2024, Recursion Pharmaceuticals had annual revenue of 58.84M with 34.10% growth.
Revenue (ttm)
43.53M
Revenue Growth
-32.98%
P/S Ratio
42.55
Revenue/Employee
$73,549
Employees
800
Market Cap
$2.50B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
58.84M14.96M+134.10%
Dec 31, 2023
43.88M4.20M+110.57%
Dec 31, 2022
39.68M29.68M+396.81%
Dec 31, 2021
10.00M6.59M+293.00%
Dec 31, 2020
3.41M1.70M+199.47%
Dec 31, 2019
1.71M